- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 16/42 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against immunoglobulins (anti-idiotypic antibodies)
Patent holdings for IPC class C07K 16/42
Total number of patents in this class: 1032
10-year publication summary
|
70
|
81
|
92
|
85
|
86
|
100
|
96
|
108
|
107
|
36
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
28 |
| Novartis AG | 11238 |
27 |
| Genentech, Inc. | 3742 |
26 |
| Xencor, Inc. | 403 |
23 |
| F. Hoffmann-La Roche AG | 7958 |
22 |
| Sanofi | 3836 |
21 |
| Hoffmann-La Roche Inc. | 3060 |
20 |
| Janssen Biotech, Inc. | 1347 |
19 |
| H. Lundbeck A/S | 1252 |
18 |
| Institut Pasteur | 798 |
13 |
| Genmab A/S | 382 |
13 |
| Ablynx N.V. | 377 |
12 |
| Quiapeg Pharmaceuticals AB | 46 |
12 |
| The Regents of the University of California | 18943 |
11 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
11 |
| Amgen Inc. | 3779 |
10 |
| Academia Sinica | 888 |
8 |
| Animal Allergy Clinical Laboratories Inc. | 15 |
8 |
| BAC IP B.V. | 12 |
8 |
| Juno Therapeutics, Inc. | 365 |
8 |
| Other owners | 714 |